RecruitingNCT05950282

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Measuring Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Sponsor

Ali Chappell

Enrollment

150 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Obesity Insulin Resistance Hyperinsulinism Metabolic Syndrome Polycystic Ovary Syndrome

Summary

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is a research analysis examining how fasting insulin levels and insulin resistance (measured by a calculation called HOMA-IR) vary across different groups of people based on age, sex, race or ethnicity, body weight (BMI), and whether they have polycystic ovary syndrome (PCOS). The goal is to establish better reference ranges for these common metabolic tests. **You may be eligible if...** - You are 18 years of age or older - You are of any sex and any racial or ethnic background - You have a range of body weights (any BMI) - You have or do not have a PCOS diagnosis **You may NOT be eligible if...** - You are under 18 years old - You have another endocrine (hormone) disorder that affects insulin levels, such as an insulin-secreting tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.